158 related articles for article (PubMed ID: 16928243)
21. Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab.
Kyrtsonis MC; Siakantaris MP; Kalpadakis C; Dimopoulou MN; Vassilakopoulos TP; Kontopidou FN; Antoniou C; Korkolopoulou P; Panayiotidis P; Pangalis GA
Eur J Haematol; 2006 Oct; 77(4):300-3. PubMed ID: 16856917
[TBL] [Abstract][Full Text] [Related]
22. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.
Kerl K; Prins C; Saurat JH; French LE
Br J Dermatol; 2006 Dec; 155(6):1197-200. PubMed ID: 17107389
[TBL] [Abstract][Full Text] [Related]
23. [In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery].
Elfatoiki FZ; Longvert C; Clerici T; Bourgault-Villada I; Roudier-Pujol C; Vasseur E; Saiag P
Ann Dermatol Venereol; 2014 Feb; 141(2):106-10. PubMed ID: 24507204
[TBL] [Abstract][Full Text] [Related]
24. [Clinical studies with sorafenib (Nexavar) in metastatic melanoma].
Hauschild A
J Dtsch Dermatol Ges; 2007 Apr; 5(4):345. PubMed ID: 17376105
[No Abstract] [Full Text] [Related]
25. Complete and long-lasting regression of disseminated multiple skin melanoma metastases under treatment with cyclooxygenase-2 inhibitor.
Lejeune FJ; Monnier Y; Rüegg C
Melanoma Res; 2006 Jun; 16(3):263-5. PubMed ID: 16718274
[TBL] [Abstract][Full Text] [Related]
26. Local and intralesional therapy of in-transit melanoma metastases.
Testori A; Faries MB; Thompson JF; Pennacchioli E; Deroose JP; van Geel AN; Verhoef C; Verrecchia F; Soteldo J
J Surg Oncol; 2011 Sep; 104(4):391-6. PubMed ID: 21858834
[TBL] [Abstract][Full Text] [Related]
27. Intratumoral therapy with interferon-alpha in a locoregional advanced malignant blue nevus: a brief communication.
von Moos R; Schaffner R; Cathomas R; Grimm B
J Immunother; 2010 Jan; 33(1):92-5. PubMed ID: 19952952
[TBL] [Abstract][Full Text] [Related]
28. Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin.
Rodríguez-Cuevas S; Barroso-Bravo S; Almanza-Estrada J; Cristóbal-Martínez L; González-Rodríguez E
Arch Med Res; 2001; 32(4):273-6. PubMed ID: 11440782
[TBL] [Abstract][Full Text] [Related]
29. [Interferon therapy in malignant melanoma].
Stadler R; Garbe C
Z Hautkr; 1990 May; 65(5):504-7. PubMed ID: 1696048
[TBL] [Abstract][Full Text] [Related]
30. Chemoablation of metastatic melanoma using intralesional Rose Bengal.
Thompson JF; Hersey P; Wachter E
Melanoma Res; 2008 Dec; 18(6):405-11. PubMed ID: 18830132
[TBL] [Abstract][Full Text] [Related]
31. Angiosarcoma of the scalp and face: failure of an interferon alpha treatment.
Guillot B; Raison-Peyron N; Acevedo M; Meunier L; Dandurand M; Meynadier J
Eur J Dermatol; 2000 Jun; 10(4):300-2. PubMed ID: 10846259
[TBL] [Abstract][Full Text] [Related]
32. Complete remission of cutaneous and subcutaneous melanoma metastases of the scalp with imiquimod therapy.
Heber G; Helbig D; Pönitzsch I; Wetzig T; Harth W; Simon JC
J Dtsch Dermatol Ges; 2009 Jun; 7(6):534-6. PubMed ID: 19250248
[TBL] [Abstract][Full Text] [Related]
33. Single-institution outcome of high-dose interleukin-2 (HD IL-2) therapy for metastatic melanoma and analysis of favorable response in brain metastases.
Powell S; Dudek AZ
Anticancer Res; 2009 Oct; 29(10):4189-93. PubMed ID: 19846971
[TBL] [Abstract][Full Text] [Related]
34. Clinical complete long-term remission of a patient with metastatic malignant melanoma under therapy with indisulam (E7070).
Baur M; Gneist M; Owa T; Dittrich C
Melanoma Res; 2007 Oct; 17(5):329-31. PubMed ID: 17885589
[TBL] [Abstract][Full Text] [Related]
35. Two cases of malignant melanoma of the toe developed skin ulcers following local injection of natural beta-interferon.
Kurashige Y; Irisawa R; Abe N; Saito M; Tsuboi R
J Dermatol; 2012 Dec; 39(12):1037-8. PubMed ID: 22758215
[No Abstract] [Full Text] [Related]
36. Metastatic melanoma. The latest treatment options.
Gale D
Adv Nurse Pract; 1998 May; 6(5):42-6. PubMed ID: 9633289
[No Abstract] [Full Text] [Related]
37. Complete response in a cutaneous facial metastatic nodule from renal cell carcinoma after hypofractionated radiotherapy.
Gay HA; Cavalieri R; Allison RR; Finley J; Quan WD
Dermatol Online J; 2007 Oct; 13(4):6. PubMed ID: 18319003
[TBL] [Abstract][Full Text] [Related]
38. Detailed protocol for administration of intralesional IL-2 for the treatment of Stage IIIc and IV M1a metastatic melanoma based on current NCCN guidelines.
Patel F; Wilken R; Burrall B; Martinez S; Wells V; King B; Maverakis E
Dermatol Online J; 2014 Nov; 20(11):. PubMed ID: 25419744
[TBL] [Abstract][Full Text] [Related]
39. Metastatic melanoma: scientific rationale for sorafenib treatment and clinical results.
Egberts F; Kahler KC; Livingstone E; Hauschild A
Onkologie; 2008 Jul; 31(7):398-403. PubMed ID: 18596389
[TBL] [Abstract][Full Text] [Related]
40. Systemic phototoxicity following intralesional rose bengal for subcutaneous melanoma metastases.
Wiener M; Damian DL; Thompson JF
Dermatology; 2008; 216(4):361-2. PubMed ID: 18292654
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
